Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis.
Gene-expression signatures: biomarkers toward diagnosing multiple sclerosis.
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
Optical Coherence Tomography in Multiple Sclerosis.
JC polyomavirus mutants escape antibody-mediated neutralization.
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study.
CCL genes in multiple sclerosis and systemic lupus erythematosus.
The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.
Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK.
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
Individual Neuronal Subtypes Exhibit Diversity in CNS Myelination Mediated by Synaptic Vesicle Release.
Bilateral optic neuritis in a patient with Behçet's disease who respond to therapeutic plasma exchange.
Movement and structure of mitochondria in oligodendrocytes and their myelin sheaths.
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997-2008.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study.
[Immunomodulation and neuroprotection in optic neuritis].
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis.
Fatigue and Comorbidities in Multiple Sclerosis.
[Th17-mediated relapsing-remitting multiple sclerosis is nonresponsive to interferon-β1b].
Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions.

Pages